A case report of blastic plasmacytoid dendritic cell neoplasm in a hispanic child

Tanchiva, Katy Ordoñez; Chavez, Pamela Contreras; Guevara, Silvana Lucero Loli; Vicuña, Carlos Rodrigo Quispe; Bhardwaj, Neharika; Lansigan, Frederick; Deconinck, Eric

doi:10.1016/j.lrr.2021.100262

Cited by 1 publication

(1 citation statement)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, due to the paucity of cases, the utility of allogeneic hematopoietic stem cell transplantation in rst remission remains unclear for the pediatric patients [19]. CNS, serving as a sanctuary for blasts, is likely the origin of relapse; regular prophylactic intrathecal chemotherapy is necessary to maintain remission in these patients [32]. Innovative therapy targeting the ubiquitous aberrantly overexpressed interleukin-3 receptor alpha/CD123 with the immunotoxin SL-401 and the more recent anti-CD123 CAR-T therapy have reported promising results [21,[33][34].…”

Section: Discussionmentioning

confidence: 99%

Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report

Zheng

Betts

Dwyre

et al. 2023

Preprint

View full text Add to dashboard Cite

Background: Herein, we present the second documented case of a rare pediatric lower extremity unilateral unilocular cutaneous BPDCN in a relatively asymptomatic Hispanic child who had unusual initial transient improvement from antibiotic treatment. Case presentation: A well-nourished 12-year-old Hispanic male with no significant past medical history developed a sizable progressively enlarging lesion on his right inner calf of approximately two months duration after a ground level fall. Review of systems noted night sweats. All imaging findings were unremarkable except for subcutaneous soft tissue ill-defined infiltrative swelling. Routine laboratory findings were non-contributory. The differential of chronic atypical infectious etiology was initially favored. Interestingly, it did have transient improvement with drainage and antibiotic treatment (Cephalexin/Keflex, 500mg). Approximately two months later, the lesional appearance worsened and patient was eventually diagnosed with blastic plasmacytoid dendritic cell neoplasm. Conclusion: Pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive neoplastic process involving precursor plasmacytoid dendritic cells. Diagnostic evaluation of this intricate heterogeneous entity necessitates the incorporation of various clinical and laboratory findings. Given the challenging nature of this entity, it is imperative to arrive at timely diagnosis with tissue biopsy and initiate appropriate prompt management.

show abstract